comparemela.com

Latest Breaking News On - Parity responsible technology fund - Page 1 : comparemela.com

Follow the Money: Single-Cell Multiomics, Data Networks, Security

April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.   $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release.

Data Privacy Startup TripleBlind Raises $8 2 Million in Seed Funding

By Eduard Kovacs on March 01, 2021 TripleBlind, a Kansas City, Missouri-based startup that provides data privacy solutions, on Monday announced raising $8.2 million in seed funding. The oversubscribed funding round was led by Dolby Family Ventures, with participation from several companies and angel investors. Investors include Okta Ventures, NextGen Venture Partners, Operator Partners, Wavemaker Three-Sixty Health, AVG Basecamp Fund, Anorak Ventures, Quiet Capital, Clocktower Technology Ventures, Parity Responsible Technology Fund, Manresa Ventures, Accenture Ventures, Flyover Capital and KCRise Fund. TripleBlind told SecurityWeek that it emerged from stealth mode in November 2020, when Accenture announced a strategic investment in the company. Founded in 2019, TripleBlind has developed a de-identification and data privacy solution that enables organizations to share, use and monetize sensitive information including personal, financial and health data without the fear of vi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.